“We are excited for NAMSA to serve as an exclusive partner to help patients access joimax®’ endoscopic technologies,” Joimax General Manager Maximilian Ries said in a July 21 news release. “We’re optimistic that with NAMSA’s assistance, and the nearly 5,000 clinical papers on endoscopic spine surgery, we will continue to expand coverage of this important, minimally-invasive technology.”
Bringing new medical devices to the market can be complicated, and “global medical device organizations sometimes lack the proper context and contacts when distinguishing effective reimbursement and commercialization strategies,” according to NAMSA’s website.
Joimax develops and markets complete systems for endoscopic and minimally invasive spine surgery. As a contract research organization focused on medical devices, Irvine, Calif.-based NAMSA helps companies develop medical devices from start to finish, including testing, quality assurance and clinical research.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.